3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
3
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Urologic Neoplasms
1
Thyroid Neoplasms
1
Soft Tissue Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma, Embryonal
1
Rhabdomyosarcoma, Alveolar
1
Rhabdomyosarcoma
1
Recurrence
1
Pharyngeal Neoplasms
1
Patients With Advanced or Metastatic Solid Tumors
1
PRETEXT I Hepatoblastoma
1
Neurofibromatosis 2
1
Neoplasms, Mesothelial
1
Mouth Neoplasms
1
Melanoma
1
Lymphangioleiomyomatosis
1
Lung Neoplasms
1
Kidney Neoplasms
1
Glioma
1
Glioblastoma
1
Erdheim-Chester Disease
1
Endometrial Adenocarcinoma
1
Endocrine Gland Neoplasms
1
Colonic Neoplasms
1
Castleman Disease
1
Interventions
Magnetic Resonance Spectroscopy
5
Cyclophosphamide
5
dinutuximab
3
Topotecan
3
Etoposide
3
Doxorubicin
3
Carboplatin
3
Biopsy
3
sargramostim
2
Vincristine
2
Thiotepa
2
Stem Cell Transplantation
2
Specimen Handling
2
Radiation
2
Platinum
2
Melphalan
2
Isotretinoin
2
Colony-Stimulating Factors
2
Cisplatin
2
1,2-diaminocyclohexaneplatinum II citrate
2
iberdomide
1
gallium Ga 68 dotatate
1
fludarabine
1
Watchful Waiting
1
Transurethral Resection of Bladder
1
Temozolomide
1
Razoxane
1
Radiotherapy
1
Proton Therapy
1
Observation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Ganglioneuroblastoma
×
temsirolimus
×
90 days
×
Clear all
No trials found.